Predicting lymphovascular space invasion in early-stage cervical squamous cell carcinoma using heart rate variability. [PDF]
Fang J +6 more
europepmc +1 more source
What's new? Anal squamous cell carcinoma (ASCC) incidence is increasing, with most cases occurring in immunocompetent women. ASCC risk is linked in particular to genital human papillomavirus (HPV) infection and HPV‐associated high‐grade squamous intraepithelial lesions (HSILs).
Isabel Matas +13 more
wiley +1 more source
Predicting complete response to concurrent chemoradiotherapy in locally advanced cervical squamous cell carcinoma using multi-sequence MRI data and a 2.5D deep learning algorithm integrated with crossformer model. [PDF]
Chen C +5 more
europepmc +1 more source
Oral squamous cell carcinoma presenting as a cervical lymphadenopathy.
S. Sutera +4 more
openaire +2 more sources
Nationwide Study on the Cervical Cancer Screening Pathway in Estonia
Cervical cancer remains a significant burden despite being preventable, largely due to inadequate screening participation and poor follow‐up of high‐risk women. Here, the authors investigated follow‐up rates among women who tested positive for high‐risk human papillomavirus (hr‐HPV) infection in primary screening in Estonia. Data show that more than 57
Aleksandra Šavrova +6 more
wiley +1 more source
Analysis of research hotspots on the detection of vascular endothelial growth factor C and its receptor vascular endothelial growth factor receptor-3 in cervical squamous cell carcinoma. [PDF]
Hu Y, Fang Q.
europepmc +1 more source
TCF/LEF family transcription factors: Molecular landscape and prognostic scoring in pan‐cancer
This study provides a comprehensive molecular landscape of TCF/LEF family transcription factors across 33 cancer types. We developed a TCF/LEF‐based prognostic score that correlates with immune infiltration, metabolic reprogramming and drug sensitivity, offering a robust transcriptomic signature for predicting patient survival and therapeutic response.
Zhengjun Yang +8 more
wiley +1 more source
Nimotuzumab plus concurrent chemoradiotherapy sequential maintenance treatment for locally advanced cervical squamous cell carcinoma (NOTABLE-306): a multicenter, prospective, randomized, double-blind, placebo-controlled trial. [PDF]
Wei S +14 more
europepmc +1 more source
What's New? Lung cancer patients with COVID‐19 experience significantly increased risk for severe illness and mortality. However, research addressing the effect of COVID‐19 on non‐small cell lung cancer (NSCLC) patients treated with epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitors (TKIs) remains unknown.
Wenjie Tang +13 more
wiley +1 more source
Age-related distribution of human papillomavirus genotypes in women with cervical squamous cell carcinoma from Linyi, China, 2015-2023. [PDF]
Wang Y +9 more
europepmc +1 more source

